Prognostic Value of Mean Platelet Volume in Patients With Non-ST-Elevation Acute Coronary Syndrome

Abstract

The aim of this study is to determine mean platelet volume (MPV) in a population with non-ST-elevation acute coronary syndrome (nSTEACS) and explore its relation with prognosis. Patients (n = 329) with a diagnosis of nSTEACS at admission were recruited, with a determination of MPV in the first 12 hours at admission. We also collected blood from 87 healthy controls. A composite end point of cardiovascular death and new ACS was assessed at 6-month follow-up. Patients with nSTEACS showed larger platelets (MPV: 11.0 [10.3-11.8] vs 9.2 [8.6-10.0] fL; P < .001.). In Cox regression analysis, MPV at admission was a significant predictor of cardiovascular adverse events in univariate analysis, hazard ratio (HR) 1.4 95% confidence interval (CI) 1.1-1.8; P = .018; but after adjustment with clinical variables, MPV lost its statistical significance. In conclusion, patients with nSTEACS present with larger platelets than healthy controls, however this parameter did not show an independent prognostic significance at 6-month follow-up.

Keywords

MPV acute coronary syndrome platelets prognosis

Get full access to this article

View all access options for this article.

References

Braunwald

Angiolillo

Bates

. The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention. Clin Cardiol. 2008;31(3 suppl 1):I17–I20.

Bassand

Hamm

Ardissino

. Task force for diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of European Society of Cardiology, Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28(13):1598–1660.

Karpatkin

. Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. J Clin Invest. 1969;48(6):1083–1087.

Kamath

Blann

Lip

. Platelet activation: assessment and quantification. Eur Heart J. 2001;22(17):1561–1571.

Papanas

Symeonidis

Maltezos

. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 2004;15(8):475–478.

Nadar

Blann

Lip

. Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine based antihypertensive therapy. Ann Med. 2004;36(7):552–557.

Pathansali

Smith

Bath

. Altered megakaryocyte–platelet haemostatic axis in hypercholesterolaemia. Platelets. 2001;12(5):292–297.

Kario

Matsuo

Nakao

. Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clin Lab Haematol. 1992;14(4):281–287.

Chu

Becker

Berger

. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010;8(1):148–156.

10.

Huczek

Kochman

Filipiak

. Mean platelet volume on admission predicts impaired reperfusion and longterm mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol. 2005;46(2):284–290.

11.

Burr

Holliday

Fehily

Whitehead

. Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). Eur Heart J. 1992;13(2):166–170.

12.

Pabon Osuna

Nieto Ballesteros

Morinigo Munoz

. The effect of the mean platelet volume on the short-term prognosis of acute myocardial infarct. Rev Esp Cardiol. 1998;51(10):816–822.

13.

Slavka

Perkmann

Haslacher

. Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease. Arterioscler Thromb Vasc Biol. 2011;31(5):1215–1218.

14.

Jagroop

Clatworthy

Lewin

Mikhailidis

. Shape change in human platelets: measurement with a channelyzer and visualisation by electron microscopy. Platelets. 2000;11(1):28–32.

15.

Jagroop

Mikhailidis

. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol. 2003;120(1):169–170.

16.

Matsagas

Jagroop

Geroulakos

Mikhailidis

. The effect of a loading dose (300 mg) of clopidogrel on platelet function inpatients with peripheral arterial disease. Clin Appl Thromb Hemost. 2003;9(2):115–120.

17.

Sharpe

Desai

Morris

. Increase in mean platelet volume in patients with chronic renal failure treated with erythropoietin. J Clin Pathol. 1994;47(2):159–161.

18.

Jagroop

Matsagas

Geroulakos

Mikhailidis

. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease. Platelets. 2004;15(2):117–125.

19.

Gasparyan

Ayvazyan

Mikhailidis

Kitas

. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17(1):47–58.

20.

Tello-Montoliu

Marín

Roldán

Lip

. The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage? Heart. 2010;96(3):227–228.